KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 113 filers reported holding KALVISTA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $79,755 | +5.2% | 10,147 | -9.5% | 0.00% | – |
| Q4 2022 | $75,834 | -57.4% | 11,218 | +9.7% | 0.00% | – |
| Q3 2021 | $178,000 | -95.2% | 10,222 | -93.4% | 0.00% | -100.0% |
| Q2 2021 | $3,734,000 | +4398.8% | 155,840 | +1331.8% | 0.00% | – |
| Q1 2020 | $83,000 | -36.2% | 10,884 | -3.3% | 0.00% | – |
| Q3 2019 | $130,000 | -97.7% | 11,257 | -95.6% | 0.00% | -100.0% |
| Q2 2019 | $5,729,000 | -36.2% | 258,673 | -17.6% | 0.00% | -66.7% |
| Q1 2019 | $8,980,000 | +64.4% | 313,791 | +13.5% | 0.00% | +50.0% |
| Q4 2018 | $5,461,000 | – | 276,523 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,719,576 | $38,088,000 | 25.57% |
| VHCP Management III, LLC | 637,884 | $14,129,000 | 6.60% |
| Vivo Capital, LLC | 1,359,149 | $30,105,000 | 2.82% |
| INTERWEST VENTURE MANAGEMENT CO | 388,766 | $8,611,000 | 2.78% |
| VHCP Management II, LLC | 376,889 | $8,348,000 | 2.63% |
| Samsara BioCapital, LLC | 118,500 | $2,625,000 | 1.73% |
| ACUTA CAPITAL PARTNERS, LLC | 213,000 | $4,718,000 | 1.68% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 187,599 | $4,165,000 | 1.54% |
| Ghost Tree Capital, LLC | 300,000 | $6,645,000 | 1.38% |
| Eventide Asset Management | 1,500,000 | $33,225,000 | 1.01% |